Mitsubishi UFJ Asset Management (UK)’s Integra LifeSciences IART Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,500	Closed	-$341K	–	112
2025 Q1	$341K	Buy	15,500 +6,500	+72%	+$153K	0.19%	92
2024 Q4	$204K	Buy	+9,000	New	+$196K	0.09%	105
2024 Q2	–	Sell	-3,000	Closed	-$106K	–	106
2024 Q1	$106K	Hold	3,000	–	–	0.05%	101
2023 Q4	$131K	Buy	+3,000	New	+$118K	0.07%	84
2023 Q2	–	Sell	-12,400	Closed	-$712K	–	99
2023 Q1	$712K	Sell	12,400 -6,000	-33%	-$338K	0.46%	71
2022 Q4	$1.03M	Hold	18,400	–	–	0.72%	47
2022 Q3	$779K	Hold	18,400	–	–	0.6%	55
2022 Q2	$994K	Hold	18,400	–	–	0.57%	56
2022 Q1	$1.18M	Sell	18,400 -5,000	-21%	-$329K	0.53%	66
2021 Q4	$1.57M	Hold	23,400	–	–	0.67%	49
2021 Q3	$1.6M	Hold	23,400	–	–	0.68%	45
2021 Q2	$1.6M	Hold	23,400	–	–	0.69%	52
2021 Q1	$1.62M	Hold	23,400	–	–	0.71%	50
2020 Q4	$1.52M	Buy	23,400 +5,000	+27%	+$269K	0.68%	53
2020 Q3	$869K	Hold	18,400	–	–	0.43%	62
2020 Q2	$864K	Sell	18,400 -3,000	-14%	-$147K	0.46%	63
2020 Q1	$955K	Sell	21,400 -5,000	-19%	-$262K	0.71%	52
2019 Q4	$1.54M	Hold	26,400	–	–	0.62%	41
2019 Q3	$1.59M	Hold	26,400	–	–	0.74%	36
2019 Q2	$1.47K	Sell	26,400 -8,000	-23%	-$412K	0.02%	52
2019 Q1	$1.92K	Hold	34,400	–	–	0.03%	37
2018 Q4	$1.55M	Buy	34,400 +23,000	+202%	+$1.26M	0.78%	42
2018 Q3	$750	Hold	11,400	–	–	0.02%	79
2018 Q2	$734K	Hold	11,400	–	–	0.41%	73
2018 Q1	$630K	Sell	11,400 -26,000	-70%	-$1.36M	0.42%	67
2017 Q4	$1.79M	Buy	37,400 +17,000	+83%	+$832K	1.29%	32
2017 Q3	$1.03M	Hold	20,400	–	–	0.81%	53
2017 Q2	$1.11M	Buy	+20,400	New	+$974K	0.98%	47

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s IART Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management (UK) sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 15,500 shares — an estimated $341K sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in IART in Q2 2017 and held it in 28 quarters. The position peaked at $1.79M in Q4 2017. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Mitsubishi UFJ Asset Management (UK) reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Mitsubishi UFJ Asset Management (UK) sold 15,500 Integra LifeSciences shares in Q2 2025, an estimated $341K.
Mitsubishi UFJ Asset Management (UK) first reported a position in Integra LifeSciences in Q2 2017 and held it in 28 quarters.
Mitsubishi UFJ Asset Management (UK)'s Integra LifeSciences position peaked at $1.79M in Q4 2017.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2025, filed 18 Jul 2025.